(Q35653974)

9 August 2017

1 reference

title

Optimisation of immunosuppressive therapy using pharmacokinetic principles (English)

1 reference

9 August 2017

J. Grevel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1478005

30 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1478005

30 September 2022

publication date

1 November 1992

1 reference

Clinical Pharmacokinetics

9 August 2017

1 reference

9 August 2017

23

1 reference

9 August 2017

380-390

1 reference

9 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199223050-00004

9 August 2017

0 references

cites work

High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia

1 reference

12 December 2020

Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Significance of cyclosporine pharmacokinetics.

1 reference

12 December 2020

Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy

1 reference

12 December 2020

Covariables in cyclosporine immunosuppression

1 reference

12 December 2020

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine

1 reference

12 December 2020

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

1 reference

12 December 2020

Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring

1 reference

12 December 2020

Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations

1 reference

12 December 2020

A safer approach to the clinical use of cyclosporine: the predose calculation

1 reference

12 December 2020

Very high concentration in intestinal lymph after oral, but not after intravenous, cyclosporine in the rat.

1 reference

12 December 2020

Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults

1 reference

12 December 2020

In vitro immunosuppressive effect of deoxymethylspergualin

1 reference

12 December 2020

RS-61443--a new, potent immunosuppressive agent

1 reference

12 December 2020

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

12 December 2020

Immunosuppressive properties of cyclosporin metabolites

1 reference

12 December 2020

Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants

1 reference

12 December 2020

A review of assay methods for cyclosporin. Clinical implications

1 reference

12 December 2020

Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrations

1 reference

12 December 2020

Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions

1 reference

12 December 2020

Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction

1 reference

12 December 2020

Pharmacodynamic monitoring of cyclosporin

1 reference

12 December 2020

Therapeutic drug monitoring of cyclosporin. Practical applications and limitations

1 reference

12 December 2020

Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.

1 reference

12 December 2020

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

1 reference

12 December 2020

Cyclosporin blood levels do correlate with clinical complications

1 reference

12 December 2020

The chronopharmacokinetics of cyclosporine and its metabolites in recipients of pancreas allografts

1 reference

12 December 2020

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics

1 reference

12 December 2020

Cyclosporin: measurement of fraction unbound in plasma

1 reference

12 December 2020

Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism

1 reference

12 December 2020

Clinical pharmacokinetics of cyclosporin

1 reference

12 December 2020

Corticosteroid pharmacodynamics: models for a broad array of receptor-mediated pharmacologic effects

1 reference

12 December 2020

Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients

1 reference

12 December 2020

Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration

1 reference

12 December 2020

A limited sampling strategy for the measurement of cyclosporine AUC

1 reference

12 December 2020

Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis

1 reference

12 December 2020

Interaction of cyclosporin A with human lipoproteins.

1 reference

12 December 2020

Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy.

1 reference

12 December 2020

Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment

1 reference

12 December 2020

Clinical pharmacokinetics of cyclosporin

1 reference

12 December 2020

Monitoring glucocorticoid therapy: a pharmacokinetic approach

1 reference

12 December 2020

Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation

1 reference

12 December 2020

Absorption of cyclosporine A after oral dosing

1 reference

12 December 2020

Pharmacokinetic drug interactions with cyclosporin (Part I).

1 reference

12 December 2020

The effect of obesity on cyclosporine pharmacokinetics in uremic patients

1 reference

12 December 2020

Binding of cyclosporine A to human serum lipoproteins.

1 reference

12 December 2020

Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring

1 reference

12 December 2020

Influence of demographic factors on cyclosporine pharmacokinetics in adult uremic patients

1 reference

12 December 2020

The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients

1 reference

12 December 2020

Bayesian estimation of cyclosporine clearance in bone marrow graft.

1 reference

12 December 2020

Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients

1 reference

12 December 2020

Pharmacokinetically determined cyclosporine dosage in young children

1 reference

12 December 2020

The erythromycin breath test as a predictor of cyclosporine blood levels.

1 reference

12 December 2020

Small-bowel length and the dose of cyclosporine in children after liver transplantation

1 reference

12 December 2020

Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

12 December 2020

10.2165/00003088-199223050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference